MENU
+Compare
MNTL
ETF ticker: NASDAQ
AS OF
Aug 6, 04:59 PM (EDT)
Price
$23.80
Change
-$0.05 (-0.21%)
Net Assets
473.74K

MNTL stock forecast, quote, news & analysis

The investment seeks to provide long-term growth of capital... Show more

Category: #Health
MNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for MNTL with price predictions
Aug 08, 2025

MNTL's RSI Oscillator stays in overbought zone for 12 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

MNTL broke above its upper Bollinger Band on July 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In of 32 cases where MNTL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Medtronic plc (NYSE:MDT), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Sarepta Therapeutics (NASDAQ:SRPT).

Industry description

The investment seeks to provide long-term growth of capital. Under normal circumstances, the Tema Neuroscience and Mental Health ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in neuroscience and mental health companies. A company is generally considered to be a neuroscience or mental health company that derives at least 50% of revenues from neuroscience or neurology-related diseases, or mental health. The fund is non-diversified.

Market Cap

The average market capitalization across the Tema Neuroscience and Mental Health ETF ETF is 29.75B. The market cap for tickers in the group ranges from 174.17M to 560.87B. LLY holds the highest valuation in this group at 560.87B. The lowest valued company is VYGR at 174.17M.

High and low price notable news

The average weekly price growth across all stocks in the Tema Neuroscience and Mental Health ETF ETF was 1%. For the same ETF, the average monthly price growth was 5%, and the average quarterly price growth was -6%. RNA experienced the highest price growth at 29%, while VRTX experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Tema Neuroscience and Mental Health ETF ETF was 9%. For the same stocks of the ETF, the average monthly volume growth was 25% and the average quarterly volume growth was 56%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 63
P/E Growth Rating: 77
Price Growth Rating: 61
SMR Rating: 77
Profit Risk Rating: 78
Seasonality Score: -26 (-100 ... +100)
View a ticker or compare two or three
MNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
United Satets
Phone
N/A
Web
www.tema.co